We serve Chemical Name:1-(4-butylcyclohexyl)-4-ethoxy-2,3-difluorobenzene CAS:415915-42-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-(4-butylcyclohexyl)-4-ethoxy-2,3-difluorobenzene
CAS.NO:415915-42-3
Synonyms:TRANS-1-(4-BUTYL-CYCLOHEXYL)-4-ETHOXY-2,3-DIFLUORO-BENZENE;Benzene,1-(trans-4-butylcyclohexyl)-4-ethoxy-2,3-difluoro
Molecular Formula:C18H26F2O
Molecular Weight:296.39500
HS Code:2909309090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:9.23000
Exact Mass:296.19500
LogP:5.82750
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like TRANS-1-(4-BUTYL-CYCLOHEXYL)-4-ETHOXY-2,3-DIFLUORO-BENZENE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzene,1-(trans-4-butylcyclohexyl)-4-ethoxy-2,3-difluoro physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzene,1-(trans-4-butylcyclohexyl)-4-ethoxy-2,3-difluoro Use and application,TRANS-1-(4-BUTYL-CYCLOHEXYL)-4-ETHOXY-2,3-DIFLUORO-BENZENE technical grade,usp/ep/jp grade.
Related News: Anifrolumab is a fully human monoclonal antibody that binds to subunit 1 of the type I interferon receptor, blocking the activity of type I interferons. dimethylcarbamic chloride compound with iodine chloride (1:1) manufacturers A nasal therapy, built upon on the application of a new engineered IgM antibody therapy for COVID-19, was more effective than commonly used IgG antibodies at neutralizing the COVID-19 virus in animal models, according to research recently published by The University of Texas Health Science Center at Houston (UTHealth), The University of Texas Medical Branch at Galveston (UTMB Health), the University of Houston, and IGM Biosciences, Inc. N-Acetyl-3-aza-5α-cholestanon-4 suppliers The use of the Spikevax vaccine in children from 12 to 17 years of age will be the same as in people aged 18 and above, EMA said. 2-(methylthio)ethyl 2-(4-isopropyl-4-methyl-5-oxo-4,5-dihydro-1H-imidazol-2-yl)quinoline-3-carboxylate vendor & factory.
